Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 28 smoking PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


smoking PhD Projects, Programmes & Scholarships

We have 28 smoking PhD Projects, Programmes & Scholarships

Quality of life of smokers with periodontal disease: impact of Covid-19 lockdowns

Across the UK, since 2010, there has been a gradual decrease in the number of smokers from 20.1% to 14.1% (1). Smoking cessation has a positive impact in patients with periodontal disease, and current smokers present an increased risk of tooth loss in comparison to former smokers (2). Read more

Harnessing the genetics of DNA methylation to understand context-specific gene regulation in disease

Project Background. Genome wide association studies (GWAS) have discovered many genetic associations with health outcomes. However, most GWAS signals reside in non-coding regions and it is likely that GWAS variants confer their effects through a regulatory mechanism. Read more
Last chance to apply

4-year PhD Studentship: Harnessing the genetics of DNA methylation to understand context-specific gene regulation in disease

Genome wide association studies (GWAS) have discovered many genetic associations for traits and diseases. However, most GWAS signals reside in non-coding regions (outside genes), and it is likely that GWAS variants confer their effects through modulating regulatory mechanism. Read more

Health PhD

As a PhD student in the Department for Health at Bath you will have the opportunity to undertake original, in-depth research under expert supervision working in one of the top rated research Universities in the UK. Read more

Understanding disease mechanisms in autoimmune inflammatory muscle disease

The idiopathic inflammatory myopathies are a spectrum of rare autoimmune disorders characterized by inflammation of muscle tissue (myositis), which leads to muscle weakness and fatigue, and heterogeneous systemic organ involvement. Read more

Exploring p38alpha MAPK as a therapeutic target for lung adenocarcinoma

Non-small cell lung cancer (NSCLC) is a leading cause of cancer death worldwide. Notably, the majority of patients with metastatic lung adenocarcinoma (LUAD), the most common histological subtype of NSCLC, do not survive up to 5 years (1). Read more

Filtering Results